ࡱ> {~xyz ebjbj (uSe44w%%&&&4'''ho'd(,' )ZY+(+++admel$8ڵN%Q&e`aee%%%++5vb[n[n[ne%+&+[ne[n[n&T+l%'cg8دH 3(cgD(4\$&ee[neeeee%%Kkeee eeeeeeeeeeeee4 =$: GHTF/SG3/N19:2012  FINAL DOCUMENT Global Harmonization Task Force Title: Quality management system Medical devices - Nonconformity Grading System for Regulatory Purposes and Information Exchange Authoring Group: Study Group 3 of the Global Harmonization Task Force Date: November 2nd, 2012 0 Dr. Kazunari Asanuma, GHTF Chair This document was produced by the Global Harmonization Task Force, a voluntary international group of representatives from medical device regulatory authorities and trade associations from Europe, the United States of America (USA), Canada, Japan and Australia. The document is intended to provide non-binding guidance to regulatory authorities for use in the regulation of medical devices, and has been subject to consultation throughout its development. There are no restrictions on the reproduction, distribution or use of this document; however, incorporation of this document, in part or in whole, into any other document, or its translation into languages other than English, does not convey or represent an endorsement of any kind by the Global Harmonization Task Force. Copyright 2012 by the Global Harmonization Task Force Table of Contents  TOC \o "1-9" Preface  PAGEREF _Toc329781623 \h 3 Introduction  PAGEREF _Toc329781624 \h 3 1.0 Scope  PAGEREF _Toc329781625 \h 3 2.0 Definitions  PAGEREF _Toc329781626 \h 4 2.1 Manufacturer  PAGEREF _Toc329781627 \h 4 2.2 Nonconformity  PAGEREF _Toc329781628 \h 4 2.3 Quality management system (QMS)  PAGEREF _Toc329781629 \h 4 3.0 References  PAGEREF _Toc329781630 \h 4 4.0 General  PAGEREF _Toc329781631 \h 5 4.1 Writing Nonconformities  PAGEREF _Toc329781632 \h 5 4.2 Grading of Nonconformities  PAGEREF _Toc329781633 \h 6 4.2.1 Step 1 Grading Matrix  PAGEREF _Toc329781634 \h 7 4.2.2 Step 2 Grading Escalation Rules  PAGEREF _Toc329781635 \h 9 4.3 Applying the Nonconformity Grading System  PAGEREF _Toc329781636 \h 10 4.4 Regulatory Audit Information Exchange Form  PAGEREF _Toc329781637 \h 11 4.5 Use of the Regulatory Audit Information Exchange Form  PAGEREF _Toc329781638 \h 11 5.0 Appendix A: Examples of statements of nonconformities  PAGEREF _Toc329781639 \h 14 6.0 Appendix B: Examples Illustrating Nonconformity Grading  PAGEREF _Toc329781640 \h 15  Preface This document was produced by the Global Harmonization Task Force (GHTF), a voluntary group of representatives from medical device regulatory authorities and the regulated industry. The document is intended to provide non-binding guidance for use in the regulation of medical devices, and has been subject to consultation throughout its development. It is expected that the reader is proficient with the requirements of ISO 13485:2003. There are no restrictions on the reproduction, distribution or use of this document; however, incorporation of this document, in part or in whole, into any other document, or its translation into languages other than English, does not convey or represent an endorsement of any kind by the Global Harmonization Task Force. Introduction This document is intended for regulatory authorities and auditing organizations. It introduces a standardized nonconformity grading system for regulatory purposes with a Regulatory Audit Information Exchange Form providing consistent audit information in order to enable exchange among regulatory authorities. Currently, the significance of a nonconformity related to a medical device manufacturers Quality Management System (QMS) may vary between regulatory authorities and auditing organizations. All parties will benefit from the use of a standardized and transparent grading system of QMS nonconformities. This will build the confidence necessary for the potential mutual acceptance of the results of a regulatory audit. The major and minor classification of nonconformities commonly used does not provide enough detail for global information exchange. Therefore the terms major and minor nonconformity will not be defined nor utilized in this document. The intent of this new grading system for regulatory purposes is to support the exchange of audit results that go beyond the binary concept of major and minor to a 5 level grading system of nonconformities. The regulatory authorities can determine how the audit information provided in the Regulatory Audit Information Exchange Form will be utilized within their jurisdiction. Regulatory authorities may also consider other data sources in addition to the outcome of the regulatory audits such as product evaluations, recalls, vigilance reports, etc. for regulatory oversight. Scope This document provides a method to present outcomes of regulatory audits that can be used by regulatory authorities for information exchange. It introduces a nonconformity grading system for regulatory purposes with a Regulatory Audit Information Exchange Form providing standardized results. The following are not included in the scope of this document: How to perform audits and prepare associated reports (see GHTF SG4 documents) How the Regulatory Audit Information Exchange Form will be utilized by regulatory authorities Definitions Manufacturer Any natural or legal person with responsibility for design and/or manufacture of a medical device with the intention of making the medical device available for use, under his name; whether or not such a medical device is designed and/or manufactured by that person himself or on his behalf by another person(s). (GHTF SG1/N55:2009) Nonconformity Non fulfillment of a requirement. (ISO 9000:2005, 3.6.2) Quality management system (QMS) Management system to direct and control an organization with regard to quality. (ISO 9000:2005, 3.2.3) References GHTF SG4/N28R4:2008 - Guidelines for Regulatory Auditing of Quality Management Systems of Medical Device Manufacturers - Part 1: General Requirements GHTF SG4/N30:2010 - Guidelines for Regulatory Auditing of Quality Management Systems of Medical Device Manufacturers - Part 2: Regulatory Auditing Strategy GHTF SG4/N33R16:2007 - Guidelines for Regulatory Auditing of Quality Management Systems of Medical Device Manufacturers - Part 3: Regulatory Audit Reports GHTF SG4/N83:2010 - Guidelines for Regulatory Auditing of Quality Management Systems of Medical Device Manufacturers - Part 4: Multiple Site Auditing GHTF SG4/N84:2010 - Guidelines for Regulatory Auditing of Quality Management Systems of Medical Device Manufacturers - Part 5: Audits of Manufacturer Control of Suppliers ISO 13485:2003 Medical Devices Quality Management Systems - Requirements for Regulatory Purposes ISO 9000:2005 - Quality Management Systems Fundamentals and Vocabulary ISO 17021:2011 Conformity Assessment Requirements for bodies providing audit and certification of management systems ISO 19011:2011 Guidelines for Auditing Management Systems General The following sections introduce a standardized nonconformity grading system for regulatory purposes. To enable consistent grading, guidance has been provided on how to write a nonconformity. The Regulatory Audit Information Exchange Form at the end of this document is a tool used to capture the grading so that it can be utilized in an exchange of information between interested regulatory bodies. Writing Nonconformities Regulatory audits should be performed in accordance with GHTF SG4 documents and other applicable regulatory references. The output of those audits may include nonconformities. In order for the significance of nonconformities to be characterized utilizing the nonconformity grading system described in this document, it is essential that nonconformities are clearly worded with factual and precise language that enables the reader to comprehend the actual non-fulfillment that was detected during the audit. The information presented should be an accurate representation of the reviewed records, samples and procedures, as well as interviews conducted. The nonconformity should: be a statement of nonconformity written in a clear, concise manner: be self-explanatory and related to the issue, not just be a restatement of the audit evidence, or be used in lieu of audit evidence be supported by objective evidence: justify the extent of evidence (e.g. number of records) - what exactly was found or not found, with an example(s) identify the location or basis (source document) for the evidence (e.g. in a record, procedure, interview, or visual observation) identify the specific requirements which have not been met: use the words of ISO 13485:2003 document the source of the requirement (e.g. medical device regulations, other applicable standards, procedures or requirements established by the organization, etc.) Multiple instances of non-fulfillment of a requirement should be combined into a single nonconformity unless the instances originate or relate to different aspects of a clause (see Appendix A NC #2). Examples of poorly and better worded nonconformities are provided in Appendix A. Grading of Nonconformities The nonconformity grading for regulatory purposes consists of a two-step approach that leads to calculation of a final grade for each nonconformity (Figure 1 shaded area): Step 1 - A Nonconformity Grading Matrix, which provides an initial grade Step 2 - Additional escalation rules are applied, to determine a final grade       Figure 1: Grading Overview Step 1 Grading Matrix As illustrated in Figure 1 above, the Grading Matrix is the first step in grading a nonconformity.  Figure 2: Grading Matrix The Y-axis of the Grading Matrix (Figure 2) is QMS Impact. It is related to the influence of the QMS clause on medical device safety and performance. It is vitally important to highlight that all the clauses of the standard are equally required if applicable, to effectively establish and maintain a quality management system that will meet regulatory purposes. For the purpose of improved stratification in the grading system, the clauses of the standard are divided into two categories: Indirect QMS Impact: ISO 13485:2003 clauses 4.1 through 6.3, are seen as enablers (making it possible or feasible) for the QMS processes to operate. These clauses are therefore considered to have indirect influence on medical device safety and performance. Direct QMS impact: ISO 13485:2003 clauses 6.4 through 8.5, are seen as having direct influence on design, and manufacturing controls. These clauses are therefore considered to have direct influence on medical device safety and performance. There are two basic principles that the auditors should follow when writing the nonconformity and assigning a clause number for purposes of utilizing this grading system. When the nonconformity has the potential to affect safety or performance, it should be written against the specific requirement in ISO 13485:2003 found in clauses 6.4 through 8.5, because it has direct QMS impact. When the nonconformity is against the manufacturers quality manual, procedures or requirements, is not specifically required in ISO 13485:2003 or does not impact safety or performance, then the nonconformity should be assigned to clauses 4.1 through 6.3, because it has indirect QMS impact. The X-axis of the Grading Matrix in Figure 2 is Occurrence and is divided into two categories: First: The first category addresses a nonconformity in a particular sub-clause (X.X.X) of ISO 13485:2003 identified for the first time. The first time is defined as not observed in the two previous QMS audits which evaluated the same sub-clause. Repeat: The second category is a nonconformity that has been identified within either of two previous QMS audits which evaluated the same sub-clause (X.X.X). Such a nonconformity poses an increased risk because it is an indicator that a corrective action has not been adequately taken or implemented. The two previous QMS audits which evaluated the same sub-clause was selected because: in order to assess the risk of repeat occurrence accurately, it is important to assess comparable nonconformities; historical data beyond the two previous QMS audits may not represent the current state; and review of more audit reports may be counterproductive for an efficient grading system. However, it is important to ensure that the audits reviewed for the Occurrence assessment, have at a minimum evaluated the same sub-clause. Occurrence in this document is directed at the frequency of a nonconformity cited from one audit to the next performed by the same auditing organization. It is not the occurrences of examples within a given sample size that the auditor may take to determine if a nonconformity exists during an audit. Nonconformities can often be written up against more than one clause. Therefore, it is the auditors obligation to determine the impact of the non-conformity on the QMS and assign the appropriate clause. The QMS impact of the nonconformity will determine whether the resulting clause will be Direct or Indirect. Some examples to help illustrate the grading process in Step 1 are provided below. Nonconformity where safety issues raise the grading to Direct Impact: A manufacturer distributes a product in the European Union, Canada and the US. The manufacturer has a documented procedure for notification of adverse events that meets the criteria of the European regulations, but has no references or requirements for adverse event reporting in the other jurisdictions. The medical device caused an adverse event and the manufacturer followed their procedures related to adverse event reporting. The manufacturer reported the event to the appropriate European Competent Authority and did not consider reporting it to the other jurisdictions. This nonconformity should therefore be assigned to clause 8.5 Improvement and not to 4.2 Documentation Requirements. Nonconformity where safety is not an issue that is against a self imposed requirement in a procedure leads to a starting grade with an Indirect Impact: A manufacturers procedure for a process revalidation of an injection molding process requires annual revalidation regardless of changes or process deviations. The annual revalidation was not performed, however there were no changes or process deviations noted. In this example, ISO 13485:2003 clause 7.5 does not require annual revalidation. There were no process changes or deviations and there does not appear to be a safety issue. This nonconformity should be assigned to clause 4.2 - Documentation Requirements for the manufacturer not following their own procedure and not against clause 7.5 Production and Service provision. Nonconformity where safety is an issue, that is against a self imposed requirement based on a standard leads to a starting grade of a Direct Impact: A manufacturer is utilizing standard ISO 11137-1 for validating their radiation sterilization process and the standard requires quarterly dose audits. This was not performed as required by the standard. In this example, there is a safety issue since the standard requires quarterly dose audits to assure product sterility. Therefore this nonconformity should be assigned to clause 7.5 Production and Service Provision. Nonconformity to illustrate a Repeat Occurrence: An initial nonconformity was found in 7.5.2.2 relating to a nonconformity in a sterilization process validation. A subsequent audit found a nonconformity in 7.5.2.1 in an injection molding process validation. Both nonconformities fall within 7.5.2 - Validation of Processes for Product and Service Provision. Therefore, the subsequent occurrence should be categorized as a Repeat Occurrence to the X.X.X level of the appropriate clause. NOTE: If the scenarios are altered within the examples it must be recognized that the conclusions may change. Step 2 Grading Escalation Rules The resultant grading from Step 1 is carried forward to Step 2, which is a rules-based escalation process to address areas of higher risk that have a potential to affect product safety and performance. Under this grading system the Step 1 grade is increased by 1 for each rule: Absence of a documented process or procedure The absence of a documented process or procedure will fundamentally affect consistency and effective implementation of any process. The word absent (or absence) should be used in the nonconformity statement when there is no documented process or procedure for the requirement. It is critical that this word be obvious within the nonconformity statement in order to consistently grade the nonconformity. Release of a Nonconforming Medical Device A nonconformity which resulted in the release of a nonconforming medical device to the market is direct evidence of a QMS failure. This rule in the grading system is assessing the QMS nonconformity at a higher risk, because nonconforming product is on the market and outside the control of the manufacturers QMS. If a nonconforming medical device is released under concession with adequate technical and scientific justification, then the nonconformity has been resolved. It is no longer considered a nonconforming product and the escalation rule will not be applied. Applying the Nonconformity Grading System Step 1 Using the Nonconformity Grading Matrix A. Direct or Indirect Impact: When a nonconformity is written and the clause assigned, identify whether it is direct impact (score of 3) or indirect impact (score of 1), as defined above. B. Repeat nonconformities against the same QMS sub-clause (X.X.X): The auditor should check the previous two audit reports which evaluated the same sub-clause to see if a nonconformity that is identified in the current audit was previously raised. The nonconformity does not have to be identical to the nonconformity in the previous audit, just cited to the same QMS sub-clause (X.X.X). If the nonconformity is a repeat, the grade increases by 1. Step 2 Application of Escalation Rules In this step of grading, the Nonconformity Grading Matrix is no longer used. Each rule below is applied to determine the final grade of the nonconformity. Rule 1 - Absence: Absence of a documented process or procedure of any requirement, the grade increases by 1. Rule 2 - Medical Device: Release of a Nonconforming Medical Device outside of the controls of the manufacturers QMS, the grade increases by 1. The final grade for a nonconformity under this grading scheme will be a number between 1 and 6. However, the grade of 5 was determined to be the maximum, because this represents a significantly high enough risk that some intervention is required. The differentiation between 5 and 6 was not felt to be of benefit in the grading system. Therefore, if a grade of 6 is achieved, the final grade is documented as 5. Refer to Appendix B, example #8. Regulatory Audit Information Exchange Form To enable information exchange between regulators, the following Regulatory Audit Information Exchange Form (Form) is introduced. List of NonconformitiesNonconformity Grading  Medical Device Country Specific Regulatory RequirementsNC#NonconformityISO 13485 :2003 ClauseStep 1 GradeAbsenceMedical DeviceGrade EUCANUSAAUSJPNOTHER12 Table 1 - Regulatory Audit Information Exchange Form This Form consists of three sections (see Table 1): List of Nonconformities - It is important to provide sufficient insight into the context and relevance of each nonconformity listed on the Form. The list of nonconformities provided in the Form should be identical to that provided in the audit report. Nonconformity Grading - The details of how the final nonconformity grade was obtained for nonconformities specifically against ISO 13485:2003. The use of this section of the Form provides transparency in the calculation process. Medical Device Country Specific Regulatory Requirements - Nonconformities that are within the manufacturers QMS but are outside the specific requirements within the clauses of ISO 13485:2003 should be identified in the Medical Device Country Specific Regulatory Requirements section of the Form. This area is not graded, but the auditor should reference the specific section of the applicable Regulation or Legislation against which the nonconformity is cited. Use of the Regulatory Audit Information Exchange Form When the Form is exchanged between regulatory authorities, specific information about the audit should be included with the Form. Examples include: date of the audit, scope of the audit, sites audited, auditors name(s), etc. The Nonconformity Grading section of the Form is intended to capture the grade of nonconformities against ISO 13485:2003. If a nonconformity is against a ISO 13485:2003 clause, it should at minimum be captured under the Nonconformity Grading section of the Form and graded. The intent of the Medical Device Country Specific Regulatory Requirements section is to capture additional issues outside the specific requirements of ISO 13485:2003. This section is not graded but the nonconformities are listed by regulatory jurisdictions (covered by the audit) and general regulatory requirements for that jurisdiction. Certain regulatory jurisdictions (such as Canada) may require that nonconformities against country specific regulatory requirements are written against a specific clause in the standard in the Nonconformity Grading section. Below is a completed Form with some specific examples: List of NonconformitiesNonconformity Grading Medical Device Country Specific Regulatory RequirementsNC#NonconformityISO 13485 :2003 ClauseStep 1 GradeAbsenceMedical DeviceGradeEUCANUSAAUSJPNOTHER1There is an absence of a Quality Policy in the organization.5.31+122Documented procedures for identifying training needs are not established.21 CFR 820.25Ord 169 (Article 23 subpart 2)3The injection molding process has not been validated, as per procedure DOC12345 but has not resulted in nonconforming product being released to the market.7.5.233MDD (93/42/ EEC) (Annex II)4The WIDGET"! device was sold in Canada without a medical device license. Procedure DOC12345 requires that all medical devices class II, III & IV are licensed prior to sale in Canada, according to section 26 of the CMDR. This type of NC was also cited in last years audit.4.122CMDR section 26 Nonconformity #1 An example of a nonconformity of the QMS from the requirements of ISO 13485:2003. Nonconformity #2 An example of a country specific regulatory requirement that is a nonconformity within the manufacturers QMS but more specific than the requirements of the clauses of ISO 13485:2003. Nonconformity #3 An example of a nonconformity within the QMS that is also against a country specific regulatory requirement. In this case, the nonconformity could also be written against the EU Medical Device Directive. Nonconformity #4 An example of a nonconformity to a country specific regulatory requirement that is also cited under section 4.1 of ISO 13485:2003. In this case, Canada requires all nonconformities be written against ISO 13485:2003. The Form provides a transparent and standardized way of exchanging information between regulatory authorities on the outcome of medical device regulatory audits. The intent is that this Form will be provided to the medical device manufacturer after following standard auditing procedures where potential nonconformities are routinely discussed throughout the audit and at the closing meeting of the audit (ISO 19011:2011, clause 6.4.9). It is recommended that a draft of the Form be provided at the closing meeting of the audit for sake of transparency. The grade assigned to each nonconformity should not be changed as a result of any correction(s) or corrective action(s) taken by the manufacturer, but may be amended as a result of the auditing organizations documented appeals process (ISO 17021:2011, clause 9.7). After the auditing organization has completed the audit process, the final Form should be provided to the manufacturer. The intent is also that the grading and the Form be a method to accurately capture the assessment of the audit and to provide uniformity and consistency within the process of grading nonconformities. The Form purposely does not provide a cumulative grade for the overall audit. How the Form is utilized is the decision of each regulatory authority for their appropriate assessment based on their own needs or requirements. Appendix A: Examples of statements of nonconformities Nonconformity StatementsNC #Poorly wordedImproved wordingISO 13485:2003 Clause1There was no evidence of training to the medical devices directiveThe manufacturer did not follow their own training procedure (#14) requiring training on the medical devices directive (93/42/EEC) for internal auditors.4.2.12Document control was inadequate because of multiple occurrences of obsolete documents being utilizedThe following obsolete documents were found to be in use: Obsolete version of procedure XYZ found to be in use in the calibration department Obsolete version of ABC in receiving area was found to be in use Obsolete version of design review procedure PQR was found to be in use in design department4.2.33The scheduled internal audit must be conducted and the report provided for review.There was an absence of a documented procedure for conducting internal audits 8.2.2 Appendix B: Examples Illustrating Nonconformity Grading STEP 1STEP 2Example of NonconformityISO 13485 ClauseOccurrenceSTEP 1 GradeExplanation of STEP 1 GradeAbsenceMedical DeviceFinal GradeExplanation of Final Grade1. There is no objective evidence of the establishment of quality objectives for 2011, as required in the auditee's Quality Manual. The same non conformity was cited during the audit of 2010.5.4.1 (indirect)Repeat (2010, 2011)2This is a repeat NC. Therefore, it leads to a NC grade of 2.NONO2This is not an absence of a QMS requirement. There is a documented procedure however the manufacturer could not provide objective evidence that it was being followed. As a result of this NC it is unlikely that a nonconforming product was placed on the market. Therefore the initial grade does not change.2. Management reviews are held quarterly per procedure number DOC12345. However, there is no documentation of the third quarter management review meeting for 2010. 5.6.1 (indirect)First NC1This is a first NC, leading to a NC grade of 1.NONO1This is not an absence of a QMS requirement. As a result of this NC it is unlikely that a nonconforming product was placed on the market. Therefore the initial grade does not change3. Competence, Awareness and Training processes are absent from the QMS. Documented evidence for training could not be provided. This NC was also raised in a previous QMS audit (2009, 2011). 6.2.2 (indirect)Repeat NC2This is a repeat NC. Therefore, it leads to a NC grade of 2.YESNO3The absence of a QMS requirement increases the initial grade by 1, making the final grade as 3.4. Suppliers are not adequately controlled as per procedure DOC1234. Supplier X of was replaced with Supplier Y on 1st May 2011 without approval. This is the second NC issued against the same sub-clause in a previous QMS audit (2010).7.4.1 (direct)Repeat NC4This is a repeat NC. Therefore, it leads to a NC grade of 4.NONO4This is not an absence of a QMS requirement. There is no evidence of nonconforming product being placed on the market. Therefore the initial grade does not change.5. Suppliers are not adequately controlled as per procedure DOC1234. Product XX was shipped on 2nd of September 2011 and was nonconforming due to an uncontrolled specification change made by the supplier. This is the second NC issued against the same sub-clause in a previous QMS audit (2010).7.4.1 (direct)Repeat NC4This is a repeat NC. Therefore, it leads to a NC grade of 4.NOYES5Non conforming product was placed on the market as a result of this QMS nonconformity. This increases the initial grading by 1, to a final grade of 5.6. There was no evidence of a record for control of storage conditions for a medical device with a 24 month shelf life that requires storage at 2-80C per procedure (#12345). 7.5.5 (direct)First NC 3This is a first NC, leading to a NC grade of 3.NONO3The initial grade does not change.7. There is an absence of a Quality Policy.5.3 (indirect)First NC1This is a first NC, leading to a grade of 1.YESNO2There is an absence of a QMS requirement. Therefore, the initial grade increases by 1 to a final grade of 2.8. There was an absence of the requirement for Design verification in the manufacturers QMS. As a result design changes to device model XXX were not verified prior to the product release to the market. This is the second NC issued against the same sub-clause in a previous QMS audit (2010). 7.3.5 (direct)Repeat NC4This is a repeat NC. Therefore, it leads to a NC grade of 4.YESYES5This is an absence of a requirement and non conforming product was placed on the market. Therefore the grade would be 4+2=6. However, since the maximum grade can only be 5, it will be recorded as 5.9. There was no evidence of design validation as per procedure DOC12 for device model XXX. The product was shipped to five customers.7.3.6 (direct)First NC3This is a first NC, leading to a grade of 3.NOYES4Non conforming product was placed on the market as a result of this QMS nonconformity. This increases the initial grade by 1, to a final grade of 4.  ISO & IAF 9001 Auditing Practices Group Guidance on: Documenting a Nonconformity (5 June 2009)  HYPERLINK "http://www.iso.org/tc176/ISO9001AuditingPracticesGroup" www.iso.org/tc176/ISO9001AuditingPracticesGroup  See ISO 13485:2003 clause 1.2  Justification for approach:    #ͼveSF5$ hh&5B*CJ,aJ,ph hh5B*CJ,aJ,phhdChB*CJph"jhdChB*CJUph!hdChB*CJmHphsH hdCh5B*mHphsH hdChsie5B*mHphsH%h2P5B*mHnHo(phsHtH hFhF5B*mHphsH hFhBNK5B*mHphsH hFh"5B*mHphsH hFh5B*mHphsH hFh5B*mHphsH ,MP     %^%`gda gd gda Hdhgd$ Hdha$gd$a$gdgd$a$gd$a$gd\#&'+,MNOPQXst˼tm^M^>hFhB*CJ\ph hFhFB*CJNH\phhFhFB*CJ\ph hFhFhdChB*CJ\phhdCh5B*CJphhdCh_",5B*CJphha5B*CJ phhdCh2P5B*CJ phhdCh5B*CJ ph hh5B*CJ,aJ,ph$hh,95B*CJ,NHaJ,ph hh,95B*CJ,aJ,ph   # $ , . 0 1 5 6       ڼznbOKG?4h'haCJaJhpCJaJhpha$hdChB*CJnHo(phtHhFB*CJ\phhB*CJ\phhkh9pCJ\*h Hh HB*CJH*\nHo(phtH!h HB*CJ\nHo(phtH!hRB*CJ\nHo(phtHhdChB*CJ\phhdCh_",5B*CJphhdCh5B*CJphh!fh')CJhdChB*CJph  X Z 3 4 9:rsFw !`$a$gd\gd/* UD]gd/* $UD]a$gd/*gd%^%gd %^%`gda  < T V X Z $ & \ ^ 2 4 C  b c 1278:>IJQkqɼwmh/*CJnHtHh,Sh/*CJNHnHtHh/*CJnHo(tHh,Sh/*CJnHo(tHh,Sh/*CJnHtHh,Sh/*CJaJnHo(tHhdChB*CJphhaCJaJnHo(tHhJ5CJaJnHo(tHh'haCJaJhhCJaJ hh'qrs;udu[uEu+hK|hCJOJQJ_HaJmHnHuh-mHnHu j;hUmHnHujhUmHnHuhmHnHu h\ahB*mHnHphuh9ph>C^Jjhzeh>CU^JhdChB*phhdCh5B*CJphhdChB*CJaJph(hLoh lB*CJaJnHo(phtHh/*hCJnHo(tH&'ABCDEFIJVWXrstuvwz{±±ᨗ¨¨ᨆ±±u±± j=hUmHnHu j<hUmHnHu j <hUmHnHuhmHnHu h\ahB*mHnHphu+hK|hCJOJQJ_HaJmHnHuh-mHnHujhUmHnHu j;hUmHnHu+ ()CDEFGHKLde±±ᨗ¨¨ᨆ¨¨u¨¨ j>hUmHnHu j}>hUmHnHu j>hUmHnHuhmHnHu h\ahB*mHnHphu+hK|hCJOJQJ_HaJmHnHuh-mHnHujhUmHnHu j=hUmHnHu)HGAABgdVugd>C5gdQ8qgd>C5gd>C p'(BCDEFGJKuv¹¹Ṩ¹¹ṗ¹¹Ṇ¹¹u¹ jkAhUmHnHu j@hUmHnHu jq@hUmHnHu j?hUmHnHuhmHnHu+hK|hCJOJQJ_HaJmHnHuh-mHnHujhUmHnHu jw?hUmHnHu. !;<=?@ADE{|ҸҸҸwҸljhzeh>CU j_ChUmHnHu jBhUmHnHuh\ah^JmHnHu jeBhUmHnHuh-mHnHu jAhUmHnHujhUmHnHuhmHnHu+hK|hCJOJQJ_HaJmHnHu(ELbcOPZjw張}xqxxih5~h>C] h>CNH] h>C]h%hFK] hFK]h%h>C]hA%h>C h%h>ChEh>CNH^JhEh>C^J hQhh>ChQ^J h2^JhEh2^Jhzeh>CNH^J h>C^Jhzeh>C^J h D^JhdChB*ph) &=>@BXnqr !KL_`ۼռ۳խաՆ hB^J hA%]h%hA%]h0NH^J h0^J h^J hhm^Jhdeh>C^J h2^JhEh>CNH^Jh>CNH^J h>C^JhEh>C^Jh%h>C^Jh%h>C]h>C h%h>C04`a!",23@ACDcfj$%./:;ؘ̿̿ޏoha h>Ch9p hzeh9p(hpzhpzB*CJOJQJ]^Jphhpzh>CNH^Jhpzh>C^J hE"T^J hE"TNH] hE"T]hE"Th>C] h>C]h%h>C] h%h>C hA%NHhA%h>CNH^J h>C^Jhzeh>C^JhdChB*phhBh>CB*^Jph"BC/;Hd o !!!!A"B"""gdFgdmgdmgd9pgd9pgdm & F gdVu & F gd>Cgd>CgdVu;Hwx* K M c d n !!!!e#f##########5$8$9$>$$$$$$$ % hhFh/ h NHh|'h2n hhF hhFh hFNHhF hzehFhFB*phhk2 h>ChoahoahoaB*phh9ph>Ch9pNH h>Ch9ph9ph9pB*ph4"####5$$$$&&L'M'))*)F))*5***+i++1, & Fgd9p & F gd9pgdJGgdJGgdmgdmgdF %%"%#%0%1%8%9%C%V%%%& &7&E&M&P&f&g&w&x&&&&&&&'''I'M''''''''''''''''3(K(g(ſɹɳ h^JhFNH^Jh ?hFh+ h ?hFhDyR hDyR^JhzehF^J hF^J hFNH hNHhhF hG,hF hzehF hh"hhJGNH hhDyR hhHsw hhJG2g(h(~((((((((((()))))')()*)B)C)D)F))))))))))) ** *2*5*l*o****xr hvNH h9phvhsh hF^Jh9phFNHh hvhk h9phFjhMXhF0J"U^JhMXhF^Jhzeh-NH^Jhzeh-^J h-^J hat^J hv)^JhzehFNH^JhzehF^J hF^J,******++U+g+i+l+++++++++++++/,0,2,,,,,,,,--E-F-O-P-k-o-p-}-~-------ϾϾϯ h"oh: h"ohK h"ohLoh"ohF^J h"ohA% h"ohFhF hF^Jh9ph[^J h[^Jh9phFNH^Jh9phF^Jh}hX h>he^hsh9phFNH h9phFhv21,2,P-k-..c.................$a$gdF 8h^hgd@ hdh^hgd@gdFgdmgdm^gd9p--.... .".$.&.3.H.I.].b.c.i.l.m......................Ľ⃊{sl h"ohpzh"ohD5h"oh45 h"ohD$jh"ohDU_HmHnHu jh"ohDUmHnHuh"ohF6 h"oh h"oh4 h"ohv h"oh@h"oh@5h"ohF5 h"ohFh"oh/NH h"oh/ h"ohK'....]/^/`/a/{/|/00m1n1q2r2b3c34444 6 6^gdF & FgdF & FgdFgdFgdpz $8qa$gdF$a$gdF.../#/$/./\/^/_/a/h/i/k/y//////////00,1-1n111111 22i2j2r22222223W3X333Z4\4{4444򖍖h"ohb NH h"ohb h"ohlw h"ohjh"ohF0J"Uh"oh2r15h"oh45h"ohF5jCh"ohFU h"oh@h"ohFNH h"oh4 h"ohF h"oh174444444,5;5<5H5h5v5y555555555555 6,6-6062686<6F6N6d6e6k6r666üγ⪡ypi h"ohXJh"ohFNH h"oh`^h"ohF5 h"oh h"ohh"ohtNH^Jh"ohg^Jh"oht^Jh"oh^J h"oh hh h"ohth"oh ^Jh"ohFNH^Jh"ohF^J h"ohg h"ohlw h"ohF' 6k6d788_99:::;;^=_=`@a@sCtCE & FgdFh^hgdFgd@^ & F gd@^ & F gdCgdU & F 88q^gdU & F 88q^gdj&agdF66666666677'7)7=7D7a7b7c7d7l77777777788 8888888888888888G9뿷ְְݙ֋h"ohC^J h"oh@^ h"ohh"ohU>*^Jh"ohFNHhb( h"ohVh"ohF5h"ohF^J h"ohUt h"oh^o h"ohC h"ohXJ h"ohG h"ohFjh"oh#w?0J"U.G9H9]9^9_999999999 : :::;:E:F:O:W:b:n:r:s:::::::::::::3;4;;;m;p;ƿƶƭƥƞ͞ƕxxtxkxxh"oh{-NHhE? h"oh{- h"ohd$ h"oh.m; *h"ohd$h"oh^J h"oh_$h"oh@^5h"oh@^^Jh"ohNH h"ohK h"oh h"oh@^ hh^Jh"ohK^Jh"ohN8^Jh"ohC^Jh"ohCNH^J*p;;;;;;;;;.</<n<y<<<<<<<<<=G=H=N=O=]=^=_=`=========d>йyqle hshF hF5hshF5hshF56NHhshF56 hF56hF h #hFh #hsNHh #hs5 h #hn h #hs h #h #h #hBNH h #hB h #hoh h"ohFh"oh{-NH h"oh{- h"ohd$&d>e> ??????@&@)@5@C@D@K@S@X@Y@_@`@a@@@ A AdAeAAABB*B;BABOBPBQBBBBBBBBBBB1COCQC\CaClC h&rhobP h&rh^Z h&rh h&rhF>* h&rh h&rhh&rhFNH h&rhFh&rhF5h&rhF56hhF6h;hFNHhobP h;hFhhhhF hFNH4lCmCrCsCtCuCCDD DDDDD+E,EmEEEEEEEE FFFWFgFFFFFFFFFFFGGGGGGG"G»䚖䚇䖻~zhnh;hFNH h3^hFhq/ghF>*h1 h.hFhq/ghF5hq/ghF56hhF6 h;hFh&r hFNH hyX:hFhyX:hF56 hF56hFh&rhF6 h&rhFh&rhFNH.EEGG H+HBICIpIqIII K K8K9KuMMMMgdgd^gd?gdil[gd?h^hgd & F gdFgdFgdgd^gdF & Fgdq/gC^gdF"G#GGGGG H+HHHCIPIoIpIqIIIIrJsJ K K K8K9K:KKKLLLL M MMM0M2M;MsMMMMMMMMM-N.N:NPN\NrNvNNNɼɯh+Vh>1h XhF56 hF56hhI~h.\h;h?NH h;h? h?NHh?h?h5 hF5 h5h?hF5 hhF hFNHhnhFh|8MNNTPWPPPQQQQ!R"RSTTTTTTTTT $$Ifa$gd x $Ifgd x $$Ifa$gdgd.WGgd.WG^gd> + gdFgdFNNNNO2OFOGOOOOOOPP3P4P>PMPQPRPSPVPWPXP]P`PPPPPPPPPQQQ(Q0QQQQQQQQQQ"R1R2RFR`RxR{R~Rh h hhF hNkAhF h> +5h> + hF56h XhF56 hWhFhphFNH hJ uhFhJ uhJ uNH hJ uhJ u hphF hFNHhJ uhF hF58~RRRR2S3SSSSSSSSSSSSSSSSSSTTTTTFTTTTTTTTTTTTTŷŬը՞՚zh"hXkhKK5CJNH\^JaJhXkh5CJ\^JaJhXkhKK5CJ\^JaJhKKh=q h3;NHh3;h3;_HmHnHujh=qUmHnHujh=qU_HmHnHuh.WGhm h8EhFho hFNHh" h NHh hF(TTTTTTUUUU_UbUcUdUiUjUpUqUUUUUUUUVVV!V/VVVVVVVWWW󟗐}unjnnahh.WGNHh hhUhh.WG5hhd5h[ hhKK hh.WGhKKhKK5hKKhXkh=q5CJ\^JaJhXkha-5CJ\^JaJ"hXkhKK5CJNH\^JaJhXkhKKCJ\^JaJhXkhKK5CJ\^JaJhXkhKKCJ^JaJ&TTTTTTTTTU$$Ifa$gd xok $$Ifa$gd x UUU+qq$If]q^qgd xkd$$Ifl4rr%&` &&?  A t2I}I}%44 laf4g] gp2I}I}yt xU"U#UBUIUOUWUiUpUqUtUxU|UUUUUUUUUUUUFf>qq$If]q^qgd x $Ifgd x$Ifgd xok $$Ifa$gd xUUUUUUUUUUUUUUUUUUUUUUUUUUFfԒ $Ifgd xFf $$Ifa$gd xUUUVVWXYZZZ[[5^6^m^n^^^$Ifgd>Cok $$Ifa$gdkOgdFgd 7 & F^`gd 7 & F^`gd@FF $a$gdKKgd.WGW-WeWfWWWWXX X,X7X;XCok $$Ifa$gd>C^^^/qq$If]q^qgd>Ckdz$$If+44r 1Q'& lj &j&_  A t2I}I})44 +a5f4p2I}I}ytp^^^^__"_*_;_A_B_E_I_M_Q_U_[_\_______ $Ifgd1FfNqq$If]q^qgd>C $Ifgd>C$Ifgd>Cok $$Ifa$gd>C_____________``` ` ` ` ` ````` $Ifgd[ $Ifgd>CFfǣ $$Ifa$gd>C____```*`+`1`4`5`:`;`?`@`A`o`p```````````````````׻׻הzkzkzkzkzzzzz^zhXkhPCJ^JaJhXkhtCJNH^JaJhXkhtCJ^JaJhXkh!CJ^JaJhXkh JCJ^JaJhXkh CJ^JaJhXkh`oCJ^JaJhXkhFCJNH^JaJhXkhhCJ^JaJhXkhFCJ^JaJhXkh[CJ^JaJhXkh[CJNH^JaJ$`=`>`?`A``````````aa a a a a aad $IfgdnLFf $$Ifa$gdz $Ifgd>CFf $$Ifa$gd>C $$Ifa$gd ```aaa aabRbTbbbbbbbbbcc,c.cxczccccdddddddd&d'd.d4d5d6dd󽰣|||xqmh x hIxhFhFhXkh[CJ^JaJhXkhnLCJ^JaJhXkhDCJ^JaJhXkh[CJ^JaJhXkh JCJ^JaJhXkh!CJ^JaJhXkhzCJ^JaJhXkh`oCJ^JaJhXkhtCJNH^JaJhXkhtCJ^JaJ*ddddddddd/d0d1d2d3d4d6dddheieIfJf6gC^gd xgd x & F gd xgdFFf $$Ifa$gd>Cddd!e7eieyeeeJfZfffg g g4g6g7g*hHhIhLhwhhhhhhhhhhhii ii+iĹİħĞ͆{qhhY[ht}^JhY[hF>*^JhY[hCjNH^JhY[hCj^J h^JhY[hE^JhY[hc^JhY[hjM^JhY[h(,S^JhY[h#>NH^JhY[h#>^JhY[hF^Jh xB*^Jphhph xNHhAh J hph xh xhY/&6g7gdiklllll$$If]a$gdK| $$Ifa$gdK|gdF$8q^a$gdC:+i:iGi]i^i`icidiiiiiOjQjZj_jajgjkjljnjjjjkk4k5kkkkklll;l*^JhY[h d^JhY[h-<^JhY[hE^JhY[hpD^JhY[hS ^JhY[hFNH^J h^JhY[hmhNH^JhY[hmh^JhY[hF^JhY[hu^J)lllllllllm mmmZm[mmm'n(n]n^nnnnnoooooo4p5pKpMpNpZpbpcpopypӿӯӿxq hC ohC o hC ohF huhF huh9p hF^JhXkhFCJNH^JaJhXkhFCJ^JaJhXkhQ{r5CJ\^JaJ'hXkhF5B*CJ\^JaJphhXkhF5CJ\^JaJhil[hF^Jh !hFNHhF h !hF(llllmmm`TTTTT $$Ifa$gdK|kd)$$IflF<$ T t0$6    44 lapytK|mm mcmmnH<33< $Ifgd>C $$Ifa$gdK|kd$$Ifl\<$ T t0$644 lap(ytK|nnnknnnH<333 $Ifgd>C $$Ifa$gdK|kd$$Ifl\<$ T t0$644 lap(ytK|nnnCooooDpJpH<33< $Ifgd>C $$Ifa$gdK|kdӾ$$Ifl\<$ T t0$644 lap(ytK|JpKpLpMppH;;6gdu 8q^gdFkd$$Ifl\<$ T t0$644 lap(ytK|ypzppppppppppppppqq q qqq0q5q6q7q:qdqeqzq{qqqqqqqrr8r9rrrrrrrrׄwwwwwwwwwwhXkhFCJNHaJhXkhmCJaJhXkhL5CJ\aJhXkhU5CJ\aJhXkhC o5CJ\aJhXkhF5CJNH\aJhXkhp5CJ\aJhXkhFCJaJhXkhF5CJ\aJ huhFhuhFNH.ppppppp7kd$$IfTl4F $g AAA t0)    44 la&pytLT $$Ifa$gdUpppppppqq6q7qqrrr\r_rbrdrs $Ifgdv7 $$Ifa$gd>C $Ifgd>CFf $$Ifa$gdC o$qq$If]q^qa$gdU $$Ifa$gdUrrss>s?sJsKsssssssssssssss.t/tHtIttttt3u8uJuMu]u^u~uuuuuuuuvvBvCvvvvvvvvvvvvv)w*wEwGwƸhXkhFCJH*aJhXkh{CJaJhXkhF>*CJNHaJhXkhF>*CJaJhXkhmCJaJhXkhv7CJaJhXkhFCJaJhXkhFCJNHaJ?ss=tOtXtZtttttIuJu vv&v(vfvjvmvovvvwwFf% $Ifgd{Ff0 $Ifgdv7 $$Ifa$gd>C $Ifgd>CFf;Gwwwww>x?xkxlxsxtxxxxxxxxxxxxx#y%y+y,yEyFyYyZyyyyyyyyyz zVzWzzzzzzzzzzzzz%{&{;{<{m{n{x{y{{{hXkh5!CJaJhXkhLCJaJhXkhFCJH*aJhXkhmCJaJhXkh{CJNHaJhXkh{CJaJhXkhFCJNHaJhXkhFCJaJ@wwwxxxxxxyyzzCzFzJzLzzz{{{{{{{Ff $Ifgd5!Ff $Ifgd>C $$Ifa$gd>C{{ | |8|G|P|R|||||||~-~7~9~w~{~~~JKFfFf $Ifgd>CFf $Ifgd5! $$Ifa$gd>C{{{{{ |||||"|3|4|@|A|||||||||||||}}}} }}}}0}1}M}N}c}d}}}~}}}&~'~S~T~~~~~~3hXkh0CJaJhXkhzwCJaJhXkh5!CJNHaJhXkhFCJNHaJhXkhF>*CJNHaJhXkhF>*CJaJhXkhmCJaJhXkh5!CJaJhXkhFCJaJ:3=>KN]^st,-op0_abՁwh7h xCJaJ h ah xjh ah x0J"Uhjh x0J hth xjh xUh xjh x0J"UhQhFB*phhXkhLCJaJhXkh_CJaJhXkhmCJaJhXkhFCJNHaJhXkhFCJaJ, "5679:<=?@B!gd#w?!gdFgdlFf $IfgdL $Ifgd>C $$Ifa$gd>CIn order to assist the evaluation of QMS impact for this grading system, it was designed to categorize the QMS requirements contained within ISO 13485:2003 standard at a specific sub-clause level (e.g., 6 vs. 6.2 vs. 6.2.2).  The system was assessed at several different tier levels and it was determined that the QMS impact should be started at the second sub-clause (X.X) level of standard, while the Occurrence should be started at the third sub-clause (X.X.X) level and to allow the subsequent rules to be added for further refinement of the grading system.     Nonconformity Grading System for Regulatory Purposes and Information Exchange Study Group 3 Final Document GHTF/SG3/N19:2012 November 2nd, 2012Page  PAGE 16 of  NUMPAGES 16 Nonconformity Step 1 Grading Matrix Step 2 Escalation Rules Final Nonconformity Grade ( ( ( Ձց9GQXbchlrx!35678:;=>@ACDEźŶ$h`CJ\aJmH nHo(sH tHh9ph xCJ\aJmH sH hXkh2nHtHjh1Uh1h2h xCJaJh xjh x0J"Uh#w?h xCJaJh7h xCJNHaJh7h xCJaJUh xCJaJ0BCDE $$Ifa$ $Ifgd H$a$$ !$,&dPWDj^,`a$gd`$a$gd H$a$gd2  Ÿ{l{l^N{l{l^NJh1jhXkh xCJUh*hCJhmHnHu*jhXkh xCJUhhXkh xCJhhXkh xCJhRVh~ECJH*nHo(tHh~ECJnHo(tHhRVCJnHo(tHh xh xCJaJnHo(tH"h`B*CJaJnHo(phtHh xB*CJaJphhFh xB*CJaJphh`CJaJnHo(tH $%,=>EY~~~~$a$gdD$a$gdLolkdM$$Ifl0H$04 la  JKZ[\]^_`abcdehQhFB*phhI9 jh xCJ4 jh=qh xCJ4h=qh xCJ4 jh xCJ4h x h xNHYZ\]_`bcdegdlgd=q }0&P+p,p-p.p/R!4567:p/ =!"#t$% 8 00&P:p2=/ =!"#t$% < 00&P1F:pz/ =!"#$% ;Dd=1*T  c 0A LOGO1bj:'+ZqCNF:DNn>:'+ZqCNPNG  IHDRlm8R PLTEfѿѤtRNS@*bKGDHgIFg6 cmPPJCmp0712Om9IDATxMn$;Sd@#)ԋH b Rv݈+EOtaeNM ό4#?Rf ˧fF㏻z[NBܭB~Zu^B9v'*vés_J,t8'QM 2M ?qxAޅ-> ;Xᝥ[aw 8Ww5ι<\)[ v [9ANd (Z`M{Y+*B_lM vZ}-%靺 pjRS *-F åKRNb*F0E[[;5^l\<$85xm\B!9\8+39 o9=q;/9P6e ,byˁIMClyRE2$ *zs3[yb`l]DZ_HCZNIL1wY\%˷f":jV~xN y= ӶQ9% J4x:?8\Z&nɒ j?F/T "6ugMNyڋC4d6 Ost5} *S2Dpx bniȇ2:+rqFGM;կUFkNXaԧ- SrJF<\X2d{X iLJ1_m;ül}ZZNJ-twl: o-ýC,Fs7J[L[*d&AT8ާ-:3taadWġENza1b\(Cx]e6˂ CO`Yt=Iǹ(;-0X#3rʶ4Mq8&}nf+ч "0LQ3)t8n)rhxb#ؑiq$Jb)eqqJsg}2pBrŎ _8Ub(צU0#jp} O;s'/)> PɌC$AC, U'3l k|jgT,8<P 7=X 09\ 4`o&zMN76G'\rpb#`38Zn hrahlëBsV+g:殺)vL\b[@q`dlfy_bcCnw{v ;Y 7ՒN6_B#etPv "ۑwwbsTrx.9ߝ98O 9c@'DimlWSu7b'QS 4pmqiJ՛'G6b |8dѤ)Wj g׻$(T2b;TR*<+arxx"CƝػwOT m^D^p8P8od-JrP<XFYa9 -,tr@؅,5ڨñ$€Ev;@&c9蒃yG;yIxsv8OIxuhq%qW b0"\# !d:9jjCf>S@dףHMߝqd9Tȡ!aJEQ㞮 papAAR'3Xf@4b3puqRB)5}8?΂.R\ 2V0Qný(R)@xs8ѬY'˔SöAec f=h'~LjusH9u8# a!h1~8H(^4!=E|G EI| "s{#Y\ zfr&+"TTYdyyZlB\&Xa C3mHUr9ȝ^P`8T~2֒ԅS(^^lb`:~5F/GD8_Ds(2a{KS'd嬃N q3]Gvϣ2./8[́ V+9@^Nީ+23Ár*2.7T85iLG |yQD- 8f k=JG'Cf٠&A᩷]Pr ϲ'@Ȣsp}|Ƨ0gu FLXL׾k7'OQ#] t3pCmK76hsh8f_?< /Cbs?xv_ #~M+ *$pDΔ c8LzzMy~jԹpp֝9JT$4#vNHqinJ+=" Ơf`^=8AS7| !UACA%!$6}G_S݅%A8KgC|{ǡc`{PQ"0 :M㆔pGǮAـaq5=IcdDIr@(#D .t7|Q ~n[8 q"ʙC5,8Ri/ SuUAߡ(}f?%I8+Apj!aVzP '1W0q7*E窓oZP#sB,=h?߾AucPjs8yf 9.8|CI8!:JˡN*f#0WgUaҹZ&@r8  ,&?&W X9@zMs%,HCrW/+nۏp␠}} qja8|[AA02U@n8p8ܬp\!a~Y39<xy1ȠI; ܤ- '\| ջ&8h[}nF?JM@ aAQrg9kUC*g@p>u%׳ʈ!Xδ2võ;ҹ9w}j~P#ǁ ~@79+_e 8\Q,ݛ8\ˮˮ5c99 pq#{LrݏfzPyإL+8oeX8\fq 9\s sK/5ǒ*v=r` I 88 -r8v. p3\73Sw\ P*gg p c3Q:HE7,y_{3:Dj`4!VadNjZey,v>Der JwW߂3zٙ]AMŰ'v5̙W<=, jD^!8$dK8(XMg +S rr Q9 8(zC*U>s7> s@M1÷+ȏ{S@DCqg!9e=\s-ߚlV9yG 1 3z9D~*j^9n? 95~_k/p7?pp^Ab"?X9ځôsTw0o xBqvXǗp68L$DqqXh {>~ʖ@X?w8ݞ[nV 0[&}9Lqx` ջpчgWsAqb_w0Wp#M00CAþrW9 O `Dkڝ}71^I8H(g8\`z8TpGQ ^<$ 3kAedǸޑ怞>hj`Vp ;ƮqT2:=dk!J9<_sq꟔~o }.NbÇۃLJ㤁rB)9cV_AasЛY2x208zDWd8<ix?T9/f'GC1>݃WMSCX:EǸs*9kvaϬW&9LGy9. 19C~n9(8H$  ]r;9ds2ɽ8J{ʷkRųLn8L t_8?(m9hA`,^ MC0RDDt$oXAP.྾;0* މ9?{8??/PjCmv#w{8BC9rvqycA49fA@  "Bss57F=>,_B-';d-^l,N~Q=&ZT謀ÏOj ?3`۷C R[L0?˂xD&ch,]1ܝEHoPCj8+GTy.#=<bca\*b?~C,Xrb9.(3a7$|ػ499xKyF"[TptpXn A0/0oDPV76pK R*PU/[x"W,qxH|ᥪ/Ըe%F_fMɑzM))ӆ7ܙٕۚ;:Urrg^sU+wtYP|D8~d, ̞3HuUI<i OWf8Jwqh<&o?Ej!K U% |0w`rh<&5r9_}9jaWË?gi.i[f9%@-9&9p?u./_.L9=A%Ccn({8;-Dc^PqVМ/}9^x>9;-+A~V5]9!^s0ݫ\tE?@ šI FqnKҔJrzxFa.}"qH",a?U$AYZ 8o=_\b7;iVٹݸD&A& -5[@`c98G<zUoT_CQ?-)=Bd?_̹Du' z9o~BâЫJ!49^! G/vgcntq==pTZ<6ׯHBCaK{ 8^A}`Cߐ?b8(ϜHV~=} {`;*-ݰ0@cCnnRĵ ft&&sH|+r5^,!\ȕ 4{H͆92 2So!Š-! ߺr*%pE1Ȫy«}9d69Xuލ)9_?Af=*J %Ϙ  |ApXY!:C;/~W KpP0_&d85U\?h DꦊD؍^qi/;r?5*djqw0>b[ɷ8=yɈ;;9`b-2wrf beAZwrŸυeCq@w~=AS֠lA)Om0NW9mu8HqQY 78*{He- -NuCؚ|ڃ?saӆ~!ѧPFQD6VW%]y!> _A+9:sy/ q/0"tKgp r#q~ 0uA76qW.𴊃DŽU_#AXa9ELq9C80|Mk8h_8{q6$Bp09=9)&xdbiwqmYD8|tq0k8uFϡXoAP09)'pV9L!>i=BtTŭ~z=AA~QLC =?I9:[G2Gh V9 VsRlo29%!=ơ0.~3D6q'#'Qpޕkk9-PaZA9Luj3טMp),8fU.C BtrȖ+&C<ϵ/C=(l0a Kuq/9gE`4qx8 5.`!pTpȋ2n j졛pPd-9WONuCEBn0,8^^&PrC!@P1s(kqr8o0)ݥ2f3H8N69kChrx`pI~<P,"IWv%|θ\ lSir0! kq@bsQna KA8{wFe,9(\ױ4xo8 m U8<4!JqPz5gBaNy@842%!t90/eX`l3$A,ji-\AuN9 sxe9'HECb{k,E(_-> INؤ)K}hJSǩspON th} ` S'r"}%6]Y`sҥ%8bM]7p=/øF8kgT= p,|8h.2lpFx8Pob&5a8 BXpx`o NK800 pًÀstp8dp1;(9'Aºq &V]<kR"=kA&6pЋ92q.PBZ"8u:pX`0ќCP/7*>8] 1kEɷAsϠKJN)Hdpi]{!ok~|,C*! ]Bcz)\/٫G,QV졋 Icq9Dsr0W qx{p0XU }7jlP]NVl0 䡾'S=sW8 j=(p SaU4Xd9\1.nc&8ap8S$q~ ,1w.0uv\90u 8%a5_RP,`U8yr*!QQF\Aſ ]1G⑛(j-e0Y!- f79 Dm5o,qNCS'#ꑖC,etA+p{8Mpٜ,;d  >!_rVRοk̅p8-pX^ ⼚i;s1: rHs7Eq )=.5p7eNH=sX c;<δlXH9O|n AOhJo68̡ SpHA58 K9X%:L6gl;%R/'N7݋eJy77w8fzm#Ømr-I1Rdt7EӢgV((h0mb!N{GÉ {858C6`F$RrEe2{`{ВK CQ- aP|9&rɁ9HҍPrk z搼ghùZnğ8HPYCpțr~׹=ȼ.(b%TLe-0pRd'cGz{0e$&԰ !g048 [fl[d8e䗶p(EP)Xp`VqHNJ8v9RxvEyNXr1eH9\d3 ࠋ0Pu)zpA$MtTYcCjn6Lr w\2&uǂ JWZ#lLCy0R2<`2o+)d %!9 Hl(9NB3ޘz(S}Ptʝ9twi@.tN$A9 5*Sɝ L ǁp"|HB3T0$:G&ȨH/rqD\A:5֩7XJ~u$G;+Af\*'5@t}8UA&M*v|MbGYAq I>Ax% էrK,e4^԰! 5ݕN UE͕(Wrx8ĿR'x%>K)G&و%*|XơL{~9RĎfsAq敻t DrI(%b9UPG=w08bYsR@m ,)n堰uY7Aa˛^X)ҀA#pHUr~7 8 H Ma'`I=p(2]srd9sH!yZ JK %P gAl !D❔('<1K$C˲8T8Dsb7/9HKbӵ~!sWWx' CGdʑBfQw(7DxgWfs&wW+yyyERF@]|8KQ"u%ŹcǷJGrNr9&8/h#khg ,90{:8ټCrߑ0k8V pgWpi֥F&e%ty᭚^ w$*8ۥPNc]wdDA=@924vA͙~?p(9vo4!ֱ_I^[DQq-{r`h{{l TK NW"U GNrn8;@奈 99EC,5dS{QB5O6rP5)yAv%Vr MGmqAqnosdsF^^YAYyUct|q!.)*n u}Nvv/C+ݭ'F%Ґ>Cfm KETqKzTn%phqX?ź`8 kSFKx9 BKк9X-z9޺RoA{SlnCN +phyDg!` {EsL*4و&Cg f; pwTtHquDhnOVpk0 9X6C{"LDs?M Bjr څ0VRS\Qߺ8tchr%r+s.Xn(3{⬻փ[4KQ9!:Źt/Fא4ivAd0mYC6 3\ԀTva8UeM7 Az$*vIN^t:Y3 phdu{RvۉuSv}#vYi;u56O-o6uR@u͓?/Ph#{!jϚU9w)AL|I'q [QbQjTB Hj8zk/Uzl'@$ V&q nsḱԣΡ_(5fUR;9Т(nppRHXfaNM`Z.Wα@ǔ+0 00:.pXrvl^T.Exat5i!+ʐqXf5vqyI9|jE6>Z5Va(9Me0r=ıɡnEcFu$s`]b!f=^It˵c"\=^0m8dQQǮ vN{qꨖN^0d^wA,rgk @8A||[V(z ood8iR^5/O!mSj\갰.s]yl{Rj?t~#IENDB`}DyK _Toc329781623}DyK _Toc329781624}DyK _Toc329781625}DyK _Toc329781626}DyK _Toc329781627}DyK _Toc329781628}DyK _Toc329781629}DyK _Toc329781630}DyK _Toc329781631}DyK _Toc329781632}DyK _Toc329781633}DyK _Toc329781634}DyK _Toc329781635}DyK _Toc329781636}DyK _Toc329781637}DyK _Toc329781638}DyK _Toc329781639}DyK _Toc329781640;Dd'Z  C 6AGrading systemb;zod ,eq,: DNn:zod ,eq,PNG  IHDR#PsRGB@} pHYsgRtEXtSoftwareMicrosoft Office5q:QIDATx/pU.-###ȖȖ-q;GD"H$j I]dnͩܽ{w8 !|kw=]Ԝ/o?۽;Dw_)c]w:rsw_AcgYDuh,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0R3Fva)f=XeRJz ۅ1 `@^ H)5c@* nRjЃUy. Ԍ,]@J#BVYu0>p0>#BVYu0>a`Uy. rxRm=Xe~,c:Xe~VG5Dt1 `@^ S€z ۅ) cva)f=XeZ㧏X܃Uy. 8#%,]@xh#Sva} ``Uy. Oa4 K ܃Uy. Oa4 :Xe1VYu0>a`Uy. Oa4=`ʃUy. oix5 9XeCz ۅ*}3FvaC d5#w1 `@^ H)5c@* nRjЃUy. `H[3|sva-𸛛߯/{w{{mc^v?* nU1rljxlҞ|M74<0Rv?D#`SK#͏?oO8c<_}9@<{d3YcM|N1 a`%ޗFy# ʋ#1Կ3Fx,tǥr0p#0Fc;/ Q#`_ZFnca`Ce'~Ĺ 8/o#" 1WRП# ,a!k oW#瘗z1 = ?OGf#>ǜ #m }#=8?]5q1cY> GE^cs1V9|u6F`tj < ׫Ccrh`= x_8v#0Fc[q8q#'X>xg$V<\D?10F#ؠ狸[}g#>~~R3F0|Ew<zSc,#s#/n}K3c=1k>jO_Dn#`xTOI#0F#`UceIf#`>==ۓV#0F[+>'oƈ72G~1c`0F:4<3;#t3#0Fc鸽m"> c^ˏOZip{9^c,7DvOJ'>ՇG#?An C-O1=S}}=#0F"#* cGtN8B|p`ٻ|mtƈ5c Lj._xdXˁo10F#`q<=Rc:2Ɯrd#0q?ꞴKG##`!`})w0k?<@'.k#0Fc:(|{wH|M}h|#`N?'u#c1F. u̫n yw0F/;s=1F`X=醌{[/z10F#`ہ+b=|ɈyJc`cT0Ug1Fzt =caUWƈ]c >3i#e h=/|ncR3FAM} c4wz;ïk`U}LGd1zy'#ZZn# G^k#0F#`e[50Fvݟ=:\1c1V}Uf#^=|ܗOZyfc`M_w.7!u.= 3*I|[g>#0qe޵|]b0Fh9J_ c#`s'<|[0F1{8vbc`U1`0FcĐݫU\wϜ~ݷDXzp^bc#jx5c#``=Eqe%sK{Xcc#=ily0F#X{udGcdw[R'$:q``GۖoX_<c[ҽzFW 3c`c1'/yy~~0F#XwEc#` hBU_eߩ-0F1_-z.[_<>#c?{=tx飏'0F1o x_|k7},1F1?~ZrE1b1ep0F#0F#68Fp`G[#?F }{S# Lj!/8ըכrU7>FLҞSS眣֊ڻF 2+Aƈc1bGEL1vWwߌq ahԇ}z/8"ƈF>e쏛}T?M ݞ|Lj)se~cvM+cĂD/*Lj95FL7P=vƼ=+c _s>ƈ)@oy;sOcO+cČD;v8kE1bW6`@`X!܏@M W9}LVt;. `@@ -%0F8X,` Vt; t0_c. `@@ -%0F8X,vJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. `H<Lcvmt0!b`@^ R VYu0>01h)UVUy. `H V,]1FvJ]"#$x䄃 `@^ Z"O `@^ R ng. `H +@* n0@vaC @* n0@vaC ,vvaCKCC{:XrVYu01E+]2Y|pdvaV8"8cvaV8W{V㧻gg#ۅ-~koӀi?F?#0FQ'{/<}|{ۍg"#<%Lz^?q#0Fz:lvW=/ #`}  3J`69Djx$ݷO߻qlb3:#`iGI`s^7Pg<1>y 1t}0F`v8Y+o8aVh9p_ 8<#H|>&q׍S͏ c7F<?qVe0F`ڮ~7b$8.5.qsHxa / %C1cvUg7Ly ? qǭ1c=[)>!~2J\v^ncQ ˓5F`ξ-'gucK=#@>e2zn#H#/ZcXo5d[6<:c`pU5#`/4< yhyPG16g#_1>{^ۅ' `e;GIc4iv%{ί#F{cYl7ƒc10F8X ?'0hۆg޾Z}> `z7r?<)YvY}' }iyN3WV{>n@v|>W`,`ecca@x>4F`<* cKaVƈS/1nt/ax&7@P`5>*%@c`>?4>*Vnۅ2D V0Fnޟ^7 rcM. >6#d?~nx8DkvaXi! 3>5 S?2#ELjacv»GExv!1169UQ#A1V0FnI>\5`SaݣZƈw`cvy|kDc. >BvYC#(ˏw0+5Fe6{C<`cvw8|ΐacvh!ߚq^~# V0FnŇe1`cv|G10F8X ``c_ ! #aP_">"0F +#@\^5ÓUb6=BxiO0Fn6!0( ""0Fc#@CKt0dx#CV0Fn>yq-CҺ]}#!CnK$v0+5Fev;~q2$ۅ8XaŌvQ ã(.eHr x,`cv6/{2#`c?:< 1F8X*K~Ȑt0+dt;,}8D?|9n`3Fu;G3D8D![vaVX1c]=D\ːv0+1ݮY}O"vݟc. >rvYގ~=`vȏw0+5Fe v {C#+#@Ck7_ "n`|qlc`cv gc`c:zvYN~1[3aH?란edc`cvhvssg?4/e 0Ȁ|/70FV8Ztng]a8Ʃ8X`c],WݻX3WV0Fng=qXkWV0Fng|6D#0F8Xw;c##v(ѽ1Vt;Toh#0F8X1Vt;T1Vt;T'c##v0F8X1{SnnI7q0F`pvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PvJ]@i p(vaVt;. nۅ8Xv0+n`@PJd"Č ο} [_PJ@)!PJ@)!PJ@)!PJ@)!o=%/(;) 1bˣA?kB|? 3Yl_oք"[}5!n3o}~ky  O}!>/wC!^ߟgE!`_of;) ^ڳQ }>?3(#0FhhϏ2ce'3qC}O cc~?3#ƈ)McmO~Zce'sW3# 2FxK`{cc0F-s~G1]'CG^09#0F1 k$nK-OzE1~ןe9GL#`CcDyЗyX;!XDZ: <[1Nghw}ަ??@ !fz| z N?6LjQ Y@wBcsTyu3`I0'ƈGaLB ?.4FymyI0'}~1XfLx`ћI0'օƈo~b]ѫiyˡ/ 0fLufPI@)!\V㫜f>G `K&K!LtX " ls&8F 6yS#AMcj``?0hH0HϡBxHM8 1o>?mhh}R9~1##xr)f}sd4tXs?``x0s`۬#Z޷ds?```9UoLj9Fƈ1Lj)xxicDeFc?Ng0FpcDط1$5=\ pc_b\S9_MdRGc1bcKs~}Xψ10F#y ձq F<%`0F#1b[s<1a$|[ƈkBLji81z_HBmC~1=1k|iϩ#V:H)x_x>Lj)F1b-FcCGR64F{c30F0 1 k~Wsk,J1 pmq#ƈc3#Xh6c6FL?~FcEDůs oW?fcĔ߹Lj!c*BJ (%RBJ (%RBJ (%RBJ (%Rв(nIENDB`$$If!vh555 55?#v#v#v #v#v?:V l4  A t2I}I}%++,,,555 55?99/ /  / / / / / /  /  / / af4g] gp2I}I}yt x$$If!vh55555757555 5 5 5 75 5 5#v#v#v#v#v7#v#v#v #v #v #v 7#v :V l4n   AAAAAA t֖I}I}%)v)v)v ++,,,, , 555557555 5 5 5 75 99/ / / / / / / /  /  / / / af4g] gp֖I}I}yt xkd$$Ifl4nNr / f+U"%&',77& '&&&7&&   AAAAAA t֖I}I}%<<<<44 laf4g] gp֖I}I}yt xW$$If!vh55555757555 5 5 5 75 5 5#v#v#v#v#v7#v#v#v #v #v #v 7#v :V l4    tZI}I}%++,,,555557555 5 5 5 75 99/ / / / / / / / / /  / /  / / ag] gp֌I}I}yt=qkd<$$Ifl4Nr / f+U"%&' ''7'7'' ''''7''    tZI}I}%<<<<44 lag] gp֌I}I}yt=q$$If!vh55555757555 5 5 5 75 5 5#v#v#v#v#v7#v#v#v #v #v #v 7#v :V l    tZI}I}%,,,555557555 5 5 5 75 99/ ag] gp֌I}I}yt=qkd>$$IflNr / f+U"%&'''7'7''''''7''    tZI}I}%<<<<44 lag] gp֌I}I}yt=q$$If5!vh5 5j5 5j5_#v #vj#v #vj#v_:V +44  A t2I}I}))v++,,5 5j5 5j5_99/ /  / / / / / /  /  / / 4 +a5f4p2I}I}ytp$$If5!vh555j555555 j5 Q5 D5 5 .5 5#v#v#vj#v#v#v#v#v#v j#v Q#v D#v #v .#v #v:V +44H   AAAAAA t֖I}I}))v)v)v ++,,,, , 555j555555 j5 Q5 D5 5 .5 599/ / / / / / / /  /  / / / 4 +a5f4p֖I}I}ytpkdr$$If+44HN %1  Q P@n!%'&',j& 'j&Q&D&&.&   AAAAAA t֖I}I})<<<<44 +a5f4p֖I}I}ytp$$If5!vh555j555555 j5 Q5 D5 5 .5 5#v#v#vj#v#v#v#v#v#v j#v Q#v D#v #v .#v #v:V +4    tZI}I})++,,,555j555555 j5 Q5 D5 5 .5 599/ / / / / / / / / /  / /  / / 4 +a5p֌I}I}ytpkdE$$If+4N %1  Q P@n!%'&' j''''' 'j'Q'D''.'    tZI}I})<<<<44 +a5p֌I}I}ytpH$$If5!vh555j555555 j5 Q5 D5 5 .5 5#v#v#vj#v#v#v#v#v#v j#v Q#v D#v #v .#v #v:V +4    tZI}I})++,,,555j555555 j5 Q5 D5 5 .5 599/ / / / / / /  / / / 4 +a5p֌I}I}ytpkdf$$If+4N %1  Q P@n!%'&' j''''' 'j'Q'D''.'    tZI}I})<<<<44 +a5p֌I}I}ytpE$$If5!vh555j555555 j5 Q5 D5 5 .5 5#v#v#vj#v#v#v#v#v#v j#v Q#v D#v #v .#v #v:V +    tZI}I}),,,555j555555 j5 Q5 D5 5 .5 599/ / / / / / /  / / / 4 +a5g gp֌I}I}ytpkdO$$If+N %1  Q P@n!%'&'j''''''j'Q'D''.'    tZI}I})<<<<44 +a5g gp֌I}I}ytpE$$If5!vh555j555555 j5 Q5 D5 5 .5 5#v#v#vj#v#v#v#v#v#v j#v Q#v D#v #v .#v #v:V +    tZI}I}),,,555j555555 j5 Q5 D5 5 .5 599/ / / / / / /  / / / 4 +a5g gp֌I}I}ytpkd<$$If+N %1  Q P@n!%'&'j''''''j'Q'D''.'    tZI}I})<<<<44 +a5g gp֌I}I}ytp$$If!vh55 5T#v#v #vT:V l t0$6,55 5TpytK|$$If!vh55 55T#v#v #v#vT:V l t0$6,55 55Tp(ytK|$$If!vh55 55T#v#v #v#vT:V l t0$655 55Tp(ytK|$$If!vh55 55T#v#v #v#vT:V l t0$655 55Tp(ytK|$$If!vh55 55T#v#v #v#vT:V l t0$655 55Tp(ytK| $$If&!vh55g5#v#vg#v:V l4 AAA t0),55g5a&pytLT$$If&!v h5555v55r5r5Q5 Q #v#v#v#vv#v#vr#vQ#v Q :V l44 AAAAAAAAA tZ0))v)v, 5555v55r5Q5 Q a&f4pZytLTkd$$IfTl44 ' / |?$vrrQQ AAAAAAAAA tZ0)$$$$44 la&f4pZytLT$$If&!v h5555v55r5r5Q5 Q #v#v#v#vv#v#vr#vQ#v Q :V lF t0)5555v55r5Q5 Q a&pZytLThkd$$IfTlF ' / |?$vrrQQ t0)$$$$44 la&pZytLT$$If&!v h5555v55r5r5Q5 Q #v#v#v#vv#v#vr#vQ#v Q :V lF t0)5555v55r5Q5 Q a&pZytLThkd$$IfTlF ' / |?$vrrQQ t0)$$$$44 la&pZytLT$$If&!v h5555v55r5r5Q5 Q #v#v#v#vv#v#vr#vQ#v Q :V l' t0)5555v55r5Q5 Q a&pZytLThkd$$IfTl' ' / |?$vrrQQ t0)$$$$44 la&pZytLT$$If&!v h5555v55r5r5Q5 Q #v#v#v#vv#v#vr#vQ#v Q :V l t0)5555v55r5Q5 Q a&pZytLThkd$$IfTl ' / |?$vrrQQ t0)$$$$44 la&pZytLT$$If&!v h5555v55r5r5Q5 Q #v#v#v#vv#v#vr#vQ#v Q :V l t0)5555v55r5Q5 Q a&pZytLThkd$$IfTl ' / |?$vrrQQ t0)$$$$44 la&pZytLT$$If&!v h5555v55r5r5Q5 Q #v#v#v#vv#v#vr#vQ#v Q :V l t0)5555v55r5Q5 Q a&pZytLThkdy$$IfTl ' / |?$vrrQQ t0)$$$$44 la&pZytLT$$If&!v h5555v55r5r5Q5 Q #v#v#v#vv#v#vr#vQ#v Q :V l t0)5555v55r5Q5 Q a&pZytLThkdn$$IfTl ' / |?$vrrQQ t0)$$$$44 la&pZytLT$$If&!v h5555v55r5r5Q5 Q #v#v#v#vv#v#vr#vQ#v Q :V lF t0)5555v55r5Q5 Q a&pZytLThkdc$$IfTlF ' / |?$vrrQQ t0)$$$$44 la&pZytLT$$If&!v h5555v55r5r5Q5 Q #v#v#v#vv#v#vr#vQ#v Q :V l t0)5555v55r5Q5 Q a&pZytLThkdX$$IfTl ' / |?$vrrQQ t0)$$$$44 la&pZytLT$$If!vh55#v:V l054K SپŶK SپŶbD ppp02 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~PJ_HmH nH sH tH @`@ uXNormalCJ_H aJmH sH tH h`h  Heading 1)$ & F @&^5CJKH\aJJ@J  Heading 2$ & F@&5\@@!@  Heading 3  & F@&mH sH BB  Heading 4$@&5CJ\aJJJ  Heading 5$$@&`a$5CJHH  Heading 6$@&6B*CJ]ph3f  Heading 7Z$$ $$d%d&d'd@&NOPQa$5::  Heading 8$$@&a$X X  Heading 9 $@&^B*CJOJQJ]^JphDA`D Default Paragraph FontVi@V  Table Normal :V 44 la (k (No List X/X WEHeading 1 Char1"5CJKH\_H aJmH sH tH 4`4 0Header  !F/F F0 Header CharCJ_H aJmH sH tH 4 `"4 Footer  !F/1F F Footer CharCJ_H aJmH sH tH dCBd Body Text Indent h^h6B*CJPJ]nHph3ftH8BR8 Body Text B* ph^@^ upTOC 21 $ Sn 1$7$8$H$]S^n` CJaJR@R WEpTOC 1& $ 1$7$8$H$^`CJaJRYR  Document Map-D M OJQJ^JF@F pTOC 3 $ p0^p`0CJaJ.. TOC 4 ^.. TOC 5 ^.. TOC 6 ^.. TOC 7 ^.. TOC 8 ^.. TOC 9 ^6U`6 Hyperlink >*B*ph>@>  Footnote Text!CJaJ@&`!@ Footnote ReferenceH*@"@ Caption #xx5CJ\aJ^RB^ Body Text Indent 2 $^6B*W٤phPSRP Body Text Indent 3%^`JPbJ Body Text 2&6B*]mH phsH HrH  Balloon Text'CJOJQJ^JaJB' B Comment ReferenceCJaJLQL Body Text 3 )8qB*mH phsH .(. Line Number<<  Comment Text+CJaJ@j@ Comment Subject,5\`/` .P MM Topic 1 - & F<$CJ KH OJQJ^J_HaJ mHsHd/d -PMM Topic 1 Zchn.5CJ KH OJQJ\^J_HaJ mHsHtH b!b P MM Topic 2 / & F<&6CJOJQJ]^J_HaJmHsHb1b P MM Topic 30 & F 8< CJOJQJ^J_HaJmHsH88 PMM Empty1 _HmHsHj#j := Table Grid7:V/02b/2b dDefault 37$8$H$-B*CJOJQJ^J_HaJmHphsHtHRBR X_Standard Text bullet + 4 & F>OR> 6WE GHTF_Heading1 5 & FFaF 5WEGHTF_Heading1 Char CharTTrT 0L Block Text7p0]^p`0 _HmH sH >> 6 Headind Annex 8 & F^/^ FHeading 1 Char*5CJ KH OJQJ\^JaJ mH sH tH `/` FHeading 2 Char,56CJOJQJ\]^JaJmH sH tH ff F_Standard Text + ;ds @CJKH OJ QJ _HaJtHZ>Z FTitle<$<@&a$"5CJ KHOJQJ\^J_HaJ V/V F Title Char*5CJ KHOJQJ\^JaJ mH sH tH ,, FMM Title>RQR F MM Topic 4?xB*CJOJQJ_HaJphRQR F MM Topic 5@xB*CJOJQJ_HaJphRQR F MM Topic 6AxB*CJOJQJ_HaJphX"X F Normal IndentB$1$a$OJQJ_HaJtHr@2r FList ParagraphC$H1$VD^Ha$$CJKHOJ PJQJ _HaJnHtHPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] y&c',yRU&?[^ady   &?[^adg; y ( ( ( # q; %g(*-.46G9p;d>lC"GN~RTW3[^_`d+ilyprGw{3Ձ eACDFGHIKLMNOQSTUWYZ\]^_`bdeflmnsuwyz "1,. 6EMTUUUU^^^_`d6glmnnoJpppsw{BYeBEJPRVX[acghijkopqrtvx{|}~!-IK]y{ "3OQ_{}24^z|Wsv + . 0 y %%%%%%%%%%%%%%%%%%!ttbUX`   C 7""7""@H 0(  P4 3(  J  # "?D  L?"Text Box 2c"Ð?PK!8[Content_Types].xmlAN0EH%N@%邴K@`dOdlyLhoDX3'AL:*/@X*eRp208J妾)G,R}Q)=HiҺ0BL):T뢸WQDY;d]6O&8* VCLj"󃒝 yJ.;[wIC_ :{IOA !>Ø4 p;fɑ3׶Vc.ӵn(&poPK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!H%Gdrs/e2oDoc.xmlSێ }@7vdXqVlSU^~8F ;؛< 3lnVN.tR"4JCA??_(q)ТgMgrA vyg xo$q-s0B2=$e*&Vۈ_ׂu'{da2H>!I^ghoP~¡M%fRcÌ 9\hr8}DVKJ4kQ'{z~:r {4{Fc<∆]AY ]#XMHٽ aGmC:N6!l9npMlZ?XX hI8Ԣ9$@j/=;eɉa St]/_!ҸJd[%偷7TSVz$2p7):#IC%vuA#N,| 2C^{k );G'fPL\[#dqcԏ~PK!/2drs/downrev.xmlLN0DHHܨHTUJmnm!v.pYi4fFL4αt Qz|{F|My}U`݅4B#b !nɢ_8zg7X Q^b52Kq\h0ZN*{v~zFSۛyhaPFY{aGa dY7PK-!8[Content_Types].xmlPK-!8! /_rels/.relsPK-!H%G.drs/e2oDoc.xmlPK-!/2drs/downrev.xmlPK >  F?"Text Box 2c"Ð?PK!8[Content_Types].xmlAN0EH%N@%邴K@`dOdlyLhoDX3'AL:*/@X*eRp208J妾)G,R}Q)=HiҺ0BL):T뢸WQDY;d]6O&8* VCLj"󃒝 yJ.;[wIC_ :{IOA !>Ø4 p;fɑ3׶Vc.ӵn(&poPK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!H%Gdrs/e2oDoc.xmlSێ }@7vdXqVlSU^~8F ;؛< 3lnVN.tR"4JCA??_(q)ТgMgrA vyg xo$q-s0B2=$e*&Vۈ_ׂu'{da2H>!I^ghoP~¡M%fRcÌ 9\hr8}DVKJ4kQ'{z~:r {4{Fc<∆]AY ]#XMHٽ aGmC:N6!l9npMlZ?XX hI8Ԣ9$@j/=;eɉa St]/_!ҸJd[%偷7TSVz$2p7):#IC%vuA#N,| 2C^{k );G'fPL\[#dqcԏ~PK!/2drs/downrev.xmlLN0DHHܨHTUJmnm!v.pYi4fFL4αt Qz|{F|My}U`݅4B#b !nɢ_8zg7X Q^b52Kq\h0ZN*{v~zFSۛyhaPFY{aGa dY7PK-!8[Content_Types].xmlPK-!8! /_rels/.relsPK-!H%G.drs/e2oDoc.xmlPK-!/2drs/downrev.xmlPK >  F?"Text Box 2c"Ð?PK!8[Content_Types].xmlAN0EH%N@%邴K@`dOdlyLhoDX3'AL:*/@X*eRp208J妾)G,R}Q)=HiҺ0BL):T뢸WQDY;d]6O&8* VCLj"󃒝 yJ.;[wIC_ :{IOA !>Ø4 p;fɑ3׶Vc.ӵn(&poPK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!H%Gdrs/e2oDoc.xmlSێ }@7vdXqVlSU^~8F ;؛< 3lnVN.tR"4JCA??_(q)ТgMgrA vyg xo$q-s0B2=$e*&Vۈ_ׂu'{da2H>!I^ghoP~¡M%fRcÌ 9\hr8}DVKJ4kQ'{z~:r {4{Fc<∆]AY ]#XMHٽ aGmC:N6!l9npMlZ?XX hI8Ԣ9$@j/=;eɉa St]/_!ҸJd[%偷7TSVz$2p7):#IC%vuA#N,| 2C^{k );G'fPL\[#dqcԏ~PK!/2drs/downrev.xmlLN0DHHܨHTUJmnm!v.pYi4fFL4αt Qz|{F|My}U`݅4B#b !nɢ_8zg7X Q^b52Kq\h0ZN*{v~zFSۛyhaPFY{aGa dY7PK-!8[Content_Types].xmlPK-!8! /_rels/.relsPK-!H%G.drs/e2oDoc.xmlPK-!/2drs/downrev.xmlPK D  F?"Text Box 2s"`Ð?PK!8[Content_Types].xmlAN0EH%N@%邴K@`dOdlyLhoDX3'AL:*/@X*eRp208J妾)G,R}Q)=HiҺ0BL):T뢸WQDY;d]6O&8* VCLj"󃒝 yJ.;[wIC_ :{IOA !>Ø4 p;fɑ3׶Vc.ӵn(&poPK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!H%Gdrs/e2oDoc.xmlSێ }@7vdXqVlSU^~8F ;؛< 3lnVN.tR"4JCA??_(q)ТgMgrA vyg xo$q-s0B2=$e*&Vۈ_ׂu'{da2H>!I^ghoP~¡M%fRcÌ 9\hr8}DVKJ4kQ'{z~:r {4{Fc<∆]AY ]#XMHٽ aGmC:N6!l9npMlZ?XX hI8Ԣ9$@j/=;eɉa St]/_!ҸJd[%偷7TSVz$2p7):#IC%vuA#N,| 2C^{k );G'fPL\[#dqcԏ~PK!/2drs/downrev.xmlLN0DHHܨHTUJmnm!v.pYi4fFL4αt Qz|{F|My}U`݅4B#b !nɢ_8zg7X Q^b52Kq\h0ZN*{v~zFSۛyhaPFY{aGa dY7PK-!8[Content_Types].xmlPK-!8! /_rels/.relsPK-!H%G.drs/e2oDoc.xmlPK-!/2drs/downrev.xmlPK P2   3 "?H   L ?"Text Box 2c"`Ô?PK!8[Content_Types].xmlAN0EH%N@%邴K@`dOdlyLhoDX3'AL:*/@X*eRp208J妾)G,R}Q)=HiҺ0BL):T뢸WQDY;d]6O&8* VCLj"󃒝 yJ.;[wIC_ :{IOA !>Ø4 p;fɑ3׶Vc.ӵn(&poPK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!I~ъ)Ndrs/e2oDoc.xmlTn0 }q61]  dYɢ&)/%iv{Cf9$N')%Bsޕ͂癮-Jzެ_Zja hWH[17#4]R[#z,Mlm,pލFM#4NxJxxVL+V,34?d11yFVInA'Frkj/<̈X ̙&`Kd]YzMf6Q d޸ :ϱVgsDæez'nertq?BaCا7!:ϮpMt\c VØ4 p;fɑ3׶Vc.ӵn(&poPK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!I~ъ)Ndrs/e2oDoc.xmlTn0 }q61]  dYɢ&)/%iv{Cf9$N')%Bsޕ͂癮-Jzެ_Zja hWH[17#4]R[#z,Mlm,pލFM#4NxJxxVL+V,34?d11yFVInA'Frkj/<̈X ̙&`Kd]YzMf6Q d޸ :ϱVgsDæez'nertq?BaCا7!:ϮpMt\c VØ4 p;fɑ3׶Vc.ӵn(&poPK!8! _rels/.relsj0 }qN/k؊c[F232zQLZ%R6zPT]( LJ[ۑ̱j,Z˫fLV:*f"N.]m@= 7LuP[i?T;GI4Ew=}3b9`5YCƵkρؖ9#ۄo~e?zrPK!I~ъ)Ndrs/e2oDoc.xmlTn0 }q61]  dYɢ&)/%iv{Cf9$N')%Bsޕ͂癮-Jzެ_Zja hWH[17#4]R[#z,Mlm,pލFM#4NxJxxVL+V,34?d11yFVInA'Frkj/<̈X ̙&`Kd]YzMf6Q d޸ :ϱVgsDæez'nertq?BaCا7!:ϮpMt\c VCJP`dy 9 9 > > SSSffffq~2(#0%a>CHJ;P adyEM"-L]|#3R_~5^}Ww / eeubuuRxSxSxUxUxVxVxXxYx[x\x^x_xxyyyyyyy-"-L]|#3R_~5^}Ww / NTf4!)a}##$1%@>b>CCIIJJ KGKKTTUUUUFVxVWFWYX|XafaCbLbccddd}e=fdfffgghhhhciiQjnjjjll[lcllm0nKnnnoo&p.p~ppppdrrrrs2t_thtubuuSxSxUxUxVxVxXxYx[x\x^x_xxxyyyyyy(y*y?yAyXyZytyy $068abd1 ++--//66:W +b+ ,,",_",<,D,Q,"-P/-7-M-W-a-b-.s./G/^/0W0/70.:07@0^0j0\1 1U1[%10<1>1L_12r1s122+2/2h1282gE23d2Sh2 3!#303234!4UE4LT4|e475,?5K5z56f6h/6j6hp6'7s/7g7Ji7K}7X8T 8 8t#8C(8.8<8K8um8Gn8OD9I9qe9f:M:!Z:7y:+;pU;.m; t;Sx;-<HA<G<s<u<:=3A=P=b=>.>-E>O>j> r>x?E?C?Jo?#w?@@|!@z4@8@A A6 AMAZApABYBWC?CjHC{C D*D4DADYFDKDpDrqD EE8EbEcE]nE{E\F+FF5F08F@FFJG G>GeGG2G>OG.WGNcG HQ)HO\HeHSnHpHvHI5I MI*eI~I JJJJj?J8OJXJ0`JzJKFK-KKBNKPKMtKLLwL*LDLlLnLsLDzLMMC(MLf_g.gq/gRgq`gcglgi h=h+Yhihmhi'i0iAitnij- jDjjj}#j5jpZj^kb knkk-k@.kM0kQDkEkXkpkl l'l'l8lTplgm,m:mhmn:n/n2n5n8n}HnLoQ oC o)o/o)]o^o`o,vovopipGpipq3q4qrY'r1r:rHrPrRrnar-qrQ{r&~r sF*sY.sNHsUsKt%t- t+KtUtatntrt{tJ u@u)Xuv#v;vAv%TvZv wkwHswiuwxwzw2x\Wx\xlxdy$y(ySyzz9z2Zzpz?{{ {*{ C{M{pP{h|j| |@|uk|Zl|G}uT}Dr}t}#~$~+~.>~}_~ ."-4;<MAoyD%EOOy=Q TNT`f.abf(f??dC4|P0q3bM,{wU&& Fb~q'%+VVu{%$BKny,K4Z^m&rYxI#:#>ur~.!5~D HdpN1x67#HWiu ', 3{:A&bdu^,u+!';-@"gs&&_@vD-"~EDt p"2;F  I+PDUhs~ B)WEI`S "G) 472Q[Hcfn CqmY _&0x8WBIO_dcop5 Vc=x43Q99H=0M x"?Pxyo5,9>Mafju@$--Zhh}syJgu"26NP Xe^au9y_0SeZvB| Z\@p Sx]e+]7kht '>1;JCVW_ve tUehk"oYCj}$ad!#B14b??SY`;i=q{|'-Tf~k-.\20LemtnO{9!B"OOQH[ayuVy2J5a^F./:0DW`n] vJKmP8mW ".g3m ;eko.q/*.Oleh<@BBZh$(F:UVD[ qQ&4/d1Y] l>`|q/Sry.:14EJNTh0`K]pUtO'KMQa/)k{ w.>says 55/\Br X/3;O3]]$ (m<AGX`jyzS"CFIOXj )91uK myKNr}-I[[`lpufccos <EPhg{k<g#*y17KKQ|j f+7AA(%v59B<,F$HsHxPi4qD|A $' 5u>nyy?BR&Zos!f"-27(;[Ce]!013QX_-P\PzY_059[{V1L^}I$y-M72=cN Xir!-7N8rBDPsz7TgdR8q:5ONXmA'bdhuza(-RRZbku5vF}G 05=h^hkox/7vlwZPz-m:Am{HW3jnswwX #-06:B>CG@}0 Gb-1SRVZu{I~-):QpE2ho VOYt$ l0sATcnt} ]Cjjy{#Ru|~&@Pci^ &NDVCG*3@l9m =B1d8s "4ucpD~$>>WZb"o9p.}| #UBkzv'[)2892FToWPl5wRxSuvz}uu@8CL77FWFXvyh@h h@hbh@h0@UnknownGurney, Laila (GE Healthcare)a073zzz G*Ax Times New Roman5Symbol3. *Cx Arial7.@ Calibri;WingdingsG5  jMS Mincho-3 fg;(SimSun[SO5..[`)Tahoma7@CambriaAK Siemens Sans7Century?= *Cx Courier NewA$BCambria Math"1e ^ GGvc;vc;!24tt 2qXR ?q`g2 ! xx}D:\Documents and Settings\212008401\My Documents\GHTF\GHTF Steering Committee\Procedural Documents\ghtf document template.dotGHTF SG3 Quality management system  Medical devices - Nonconformity Grading System for Regulatory Purposes and Information ExchangeGHTF Fletcher, Tim-7y i Z'`IZ'D         Oh+'0(8DPt     GHTF SG3 Quality management system Medical devices - Nonconformity Grading System for Regulatory Purposes and Information ExchangeGHTFghtf document template.dotFletcher, Tim19Microsoft Office Word@2~@"Lc@ @$%vc՜.+,D՜.+, hp|  `;t GHTF SG3 Quality management system – Medical devices - Nonconformity Grading System for Regulatory Purposes and Information Exchange GHTF SG3 N18 Title タイトル(X` _PID_HLINKS_NewReviewCycleA<&7http://www.iso.org/tc176/ISO9001AuditingPracticesGroupN  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefgijklmnoqrstuvw|}Root Entry FN%Data 1Table ĸWordDocument (SummaryInformation(hDocumentSummaryInformation8pMsoDataStorep%"%T4EKNVTYUQBQ==2p%"%Item  PropertiesUCompObj y   F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q